Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing oxygen-containing organic compound
Reexamination Certificate
2002-03-14
2003-09-23
Prouty, Rebecca E. (Department: 1652)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing oxygen-containing organic compound
C435S190000, C435S252330, C435S320100, C536S063000, C426S007000
Reexamination Certificate
active
06623944
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a process for the preparation of D-pantothenic acid and/or a salt thereof using a microorganism of the Enterobacteriaceae family in which at least the poxB gene is attenuated.
2. Discussion of the Background
Pantothenic acid is produced worldwide in an order of magnitude of several thousand tons a year. It is used, inter alia, in human medicine, in the pharmaceuticals industry and in the foodstuffs industry. A large portion of the pantothenic acid produced is used for nutrition of stock animals such as poultry and pigs.
Pantothenic acid can be prepared by chemical synthesis, or biotechnologically by fermentation of suitable microorganisms in suitable nutrient solutions. In the chemical synthesis, DL-pantolactone is an important precursor. It is prepared in a multi-stage process from formaldehyde, isobutylaldehyde and cyanide. In further process steps, the racemic mixture is separated, D-pantolactone is subjected to a condensation reaction with &bgr;-alanine, and D-pantothenic acid is obtained.
The typical commercial form is the calcium salt of D-pantothenic acid. The calcium salt of the racemic mixture of D,L-pantothenic acid is also customary.
The advantage of the fermentative preparation by microorganisms lies in the direct formation of the desired stereoisomeric D-form, which is free from L-pantothenic acid.
Various types of bacteria, such as
Escherichia coli
(
E. coli
), Arthrobacter ureafaciens, Corynebacterium erythrogenes, Brevibacterium ammoniagenes, and also yeasts, such as Debaromyces castellii, can produce D-pantothenic acid in a nutrient solution which comprises glucose, DL-pantoic acid and &bgr;-alanine, as shown in EP-A 0 493 060. This patent furthermore shows that in the case of
E. coli
the formation of D-pantothenic acid is improved by amplification of pantothenic acid biosynthesis genes from
E. coli
which are contained on the plasmids pFV3 and pFV5 in a nutrient solution comprising glucose, DL-pantoic acid and &bgr;-alanine.
EP-A 0 590 857 and U.S. Pat. No. 5,518,906 describe mutants derived from
E. coli
strain IF03547, such as FV5714, FV525, FV814, FV521, FV221, FV6051 and FV5069, which carry resistances to various antimetabolites, such as salicylic acid, &agr;-ketobutyric acid, &bgr;-hydroxyaspartic acid, o-methylthreonine and &agr;-ketoisovaleric acid. They produce pantoic acid in a nutrient solution comprising glucose, and D-pantothenic acid in a nutrient solution comprising glucose and &bgr;-alanine. It is furthermore stated in EP-A 0 590 857 and U.S. Pat. No. 5,518,906 that after amplification of the pantothenic acid biosynthesis genes panB, panC and panD, which are said to be contained on the plasmid pFV31, in the above-mentioned strains the production of D-pantoic acid in nutrient solutions comprising glucose and the production of D-pantothenic acid in a nutrient solution comprising glucose and &bgr;-alanine is improved.
The favorable effect of enhancement of the ilvGM operon on production of D-pantothenic acid is furthermore reported in WO97/10340. Finally, the effect of enhancement of the panE gene on the formation of D-pantothenic acid is reported in EP-A-1001027.
According to the prior art, D-pantothenic acid or the corresponding salt is isolated from the fermentation broth and purified (EP-A-0590857 and WO96/33283) and accordingly used in purified form, or the fermentation broth comprising D-pantothenic acid is dried in total (EP-A-1050219) and used in particular as a feedstuffs additive.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide a novel method for the preparation of D-pantothenic acid and/or a salt thereof.
It is another object of the present invention to provide an animal feedstuffs additive comprising D-pantothenic acid and/or its salt.
These and other objects have been achieved by the present invention the first embodiment which includes a process for the preparation of D-pantothenic acid and/or a salt thereof comprising:
preparing D-pantothenic acid and/or a salt thereof by fermentation of a microorganism of the Enterobacteriaceae family in which at least a nucleotide sequence which codes for a poxB gene is attenuated, thereby attenuating an intracellular activity of pyruvate oxidase.
REFERENCES:
patent: 4278765 (1981-07-01), Debabov et al.
patent: 5518906 (1996-05-01), Hikichi et al.
patent: 0 493 060 (1992-07-01), None
patent: 0 590 857 (1994-04-01), None
patent: 1 001 027 (2000-05-01), None
patent: 1 006 193 (2000-06-01), None
patent: 1 050 219 (2000-11-01), None
patent: WO96/33283 (1996-10-01), None
patent: WO97/10340 (1997-03-01), None
patent: WO 02/29020 (2002-04-01), None
patent: WO 02 36797 (2002-05-01), None
XP-000987282 “Molecular Cloning of the Gene (poxB) Encoding the Pyruvate Oxidase ofEscherichia coli, a Lipid-Activated Enzyme” Journal of Bacteriology, Washington, D.C., vol. 160, No. 3, Dec. 1984, pp. 1088-1092.
C. Grabau, et al. Nucleic Acids Research. vol. 14, No. 13, pp. 5449-5460 (1986).
Blatter et al., Science vol. 277 pp. 1453-1462, (1997) Accession No. AE000188.
Jenson et al., Biotechnology and Bioengineering 58: pp. 191-195 (1998).
Carrier and Keasling (Biotechnology Progress 15, 58-64 (1999).
Franch and Gerdes (Current Opinion in Microbiology 3, 159-164 (2000).
Z. Qiu, et al. Journal of Biological Chemistry, vol. 272, No. 13, Issue of Mar. 28, :pp. 8611-8617 (1997).
Yano et al. (Proceedings of the National Academy of Sciences, USA 95, 5511-5515 (1998).
Wente and Schachmann (Journal of Biological Chemistry, vol. 266, No. 31, pp. 20833-20839 (1991).
Hamilton et al. (Journal of Bacteriology, vol. 171, No. 9, pp. 4617-4622 (1989).
Martinez-Morales et al. (Journal of Bacteriology, vol. 181, No. 22, pp. 7143-7148 (1999).
Boyd et al. (Journal of Bacteriology, vol. 182, No. 3, pp. 842-847 (2000).
Duncan and Coggins, Biochemical Journal, vol. 234, pp. 49-57 (1986).
Okamura-Ikeda et al., European Journal of Biochemistry, vol. 216, pp. 539-548 (1993).
Medina et al., Journal of Bacteriology, vol. 172, No. 12, pp. 7151-7156 (1990).
Velisek; Chromatographic Science, vol. 60, pp. 515-560 (1992).
Chung et al. (Proceedings of the National Academy of Sciences of the United States of America USA, vol. 86, pp. 2172-2175 (1989).
Degussa - AG
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Prouty Rebecca E.
Swope Sheridan L
LandOfFree
Process for preparation of D-pantothenic acid and/or salts... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparation of D-pantothenic acid and/or salts..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparation of D-pantothenic acid and/or salts... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3110689